What is the ampoule for tick treatment called? - briefly
The ampoule used for tick treatment is marketed as «Amitraz».
What is the ampoule for tick treatment called? - in detail
The injectable ampoule used to eliminate ticks is commonly marketed as an ivermectin solution. It contains the macrocyclic lactone ivermectin at a concentration of 1 % (10 mg mL⁻¹) and is supplied in sealed glass ampoules of 1 mL or 2 mL.
Key characteristics of the ivermectin ampoule
- Active ingredient: ivermectin, a broad‑spectrum acaricide and endectocide.
- Formulation: sterile aqueous solution, preservative‑free, compatible with intramuscular or subcutaneous injection.
- Indications: control of ectoparasites such as ticks (Ixodidae), mites, and lice in cattle, sheep, goats, and horses; off‑label use in dogs and cats under veterinary supervision.
- Dosage: typically 200 µg kg⁻¹ body weight; for heavy infestations, repeat administration after 7–14 days may be advised.
- Pharmacokinetics: rapid absorption, peak plasma concentrations within 2–4 hours, prolonged tissue residence providing residual activity for up to 21 days against ticks.
- Safety profile: high therapeutic index; contraindicated in pregnant animals at early gestation and in species with known sensitivity (e.g., certain dog breeds).
- Storage: store at 2–8 °C, protect from light; discard ampoules after the expiration date printed on the label.
Alternative injectable acaricides include doramectin (1 % solution) and eprinomectin (0.5 % solution). These products share a similar mode of action but differ in spectrum, withdrawal periods, and species‑specific approvals. Selection depends on regulatory guidelines, target tick species, and management objectives.
Proper administration requires aseptic technique, correct dose calculation based on accurate body weight, and observation of the injection site for adverse reactions. Documentation of treatment aligns with veterinary drug‑use regulations and facilitates traceability in food‑producing animals.